探索免疫抑制剂在帕金森病中的神经保护潜力
Huiam M Mubarak1, Brad A Racette2, Jordan A Killion1
1Department of Neurology, Barrow Neurological Institute, 240 W Thomas Rd, Phoenix, AZ, 85013, USA.
Parkinsonism & related disorders
|January 28, 2025
概括
某些免疫抑制剂,如塔克罗利斯和埃弗罗利斯,可能会降低患帕金森病 (PD) 的风险. 这些发现表明了针对PD进展的神经保护的潜在新疗法途径.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 的进展是一个重大的临床挑战.
- 神经炎症被认为是PD病理生理学的关键驱动因素.
- 免疫抑制剂正在被研究为潜在的PD疾病修饰疗法.
研究的目的:
- 调查免疫抑制剂的使用与患帕金森病的风险之间的关联.
- 确定可能对PD产生保护作用的特定免疫抑制药物.
主要方法:
- 一个基于人口的病例控制研究,利用医疗保险数据 (2016-2018).
- 包括207,532例PD病例和975177例对照病例 (年龄在67-110岁之间).
- 后勤回归分析以评估与37种免疫抑制剂相关的PD相对风险 (RR),控制共变量.
主要成果:
- 卡尔西纽林抑制剂 (塔克罗利木斯) 和mTOR抑制剂 (埃维洛利木斯,西罗利木斯) 与PD风险降低有关.
- 作为TNF抑制剂的克尔科利祖马布也显示了较低的PD风险.
- 即使在邦费罗尼校正后,塔克罗利斯和埃弗罗利斯也显示出显著的风险降低.
结论:
- 氨酸或mTOR抑制可能在降低PD风险方面发挥作用.
- 这些发现凸显了特定免疫抑制剂作为帕金森病疾病修饰疗法的潜力.
- 需要进一步的研究来探索这些药物用于PD中的神经保护策略.
相关概念视频
Parkinson's Disease: Treatment
194
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
194
Parkinson's Disease: Overview
451
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
451
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


